Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue

From NeurologyWire

Actavis plc (NYSE: ACT) and Allergan, Inc. (NYSE: AGN) today announced that they have entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock. Based on the closing price of Actavis shares on November 14, 2014, the transactio...

Read full article

Monday, December 08, 2014

Show last days of articles

Study Shows Link Between Cardiac Abnormalities, Sudden Unexp...

From NeurologyWire

Sudden death is more than 20 times more common in patients withepilepsy than in the general population. Defects in cardiac and respiratory function ar...Full story

Thursday, December 04, 2014

Tobacco Smoke Toxin Could Increase Pain in Spinal Cord Injur...

From NeurologyWire

A neurotoxin called acrolein found in tobacco smoke that is thought to increase pain in people with spinal cord injury has now been shown to accumulat...Full story

Preliminary Study Suggests Parkinson's Drugs Safe for the He...

From NeurologyWire

Non-ergot derived dopamine agonists used to treat Parkinson's disease may be safe for the heart, according to preliminary research presented at EuroEc...Full story

Wednesday, December 03, 2014

TBI Can Disrupt Glymphatic System and Accelerate Dementia

From NeurologyWire

A new study out today in the Journal of Neuroscience shows that traumatic brain injury can disrupt the function of the brains waste removal system. Wh...Full story

FDA Declines Approval for Intranasal Migraine Treatment

From NeurologyWire

FDA has declined approval for AVP-825, a drug-device that delivers low-dose sumatriptan powder intranasally using a novel delivery technology for the ...Full story

First MS Patients Receive Lemtrada in US

From NeurologyWire

The first US patients have initiated treatment with Lemtrada (alemtuzumab) in the commercial setting following its November 14th FDA approval for the ...Full story

Monday, December 01, 2014

Researchers Identify Chemical Compound That Decreases Effect...

From NeurologyWire

A team of researchers, led by a biomedical scientist at the University of California, Riverside, reports in this weeks issue of the Proceedings of the...Full story

Elderly Brains Learn, but Maybe Too Much

From NeurologyWire

A new study led by Brown University reports that older learners retained the mental flexibility needed to learn a visual perception task but were not ...Full story

FDA Accepts Dysport for Review

From NeurologyWire

(FDA) has accepted for review Ipsen's supplemental Biologics License Application (sBLA) for Dysport (abobotulinumtoxinA) in the treatment of upper lim...Full story

Wednesday, November 26, 2014

Researchers Convert Human Skin Cells into Sensory Neurons

From NeurologyWire

A team led by scientists from The Scripps Research Institute (TSRI) has found a simple method to convert human skin cells into the specialized neurons...Full story

Tuesday, November 25, 2014

FDA Warns About Case of Rare Brain Infection PML With MS dru...

From NeurologyWire

Tuesday afternoon, FDA released a warning saying that a patient with multiple sclerosis (MS) who was being treated with Tecfidera (dimethyl fumarate),...Full story

Test Detects Early Brain Damage in Football Players

From NeurologyWire

New contrast enhancing MRI developed by BGU visualizes brain injury in the blood brain barrier and offers significant diagnostic capabilities.A new, e...Full story

Monday, November 24, 2014

FDA Recall Notice: Gabapentin Capsules, USP 300mg, by Aurobi...

From NeurologyWire

Aurobindo Pharma USA is recalling lot GESB14011-A of Gabapentin Capsules, USP 300mg 100-count bottles to the consumer level. The product lot has been ...Full story

Friday, November 21, 2014

Study Identifies Early Warning Signs of Stroke Risk in Black...

From NeurologyWire

Researchers in The University of Texas at Austins College of Education have found that a blood flow impairment in blacks that puts them at higher risk...Full story

Thursday, November 20, 2014

Treatment Offers Promise for Spinal Cord Injury Patients to ...

From NeurologyWire

Case Western Reserve researcher presents findings that could free patients from ventilators, even years after injury.Case Western Reserve researchers ...Full story